CHARLESTON, S.C., April 7, 2011 (GLOBE NEWSWIRE) -- Revolutions Medical Corporation (“Revolutions Medical” or the “Company”) (OTCQB:RMCP) announces today the completion of its pre-production obligations under its manufacturing agreement with Medical Investment Group, LLC (“MIG”). The Company recently placed its first order for 2.5 million 3ml RevVac™ Auto Retractable Vacuum Safety Syringes (the “RevVac™ Safety Syringe”). This initial order will begin to fulfill commitments made to distributors since the introduction of the RevVac™ Safety Syringe during the November 2010 Medica Conference in Dusseldorf, Germany. The Company anticipates this order to be shipped and delivered during the current quarter of 2011.
